NYAS Conferences
New York Academy of Sciences
left end
Search
divider divider feedback right end
Annals of the New York Academy of Sciences Annals of the New York Academy of Sciences login

Main

Browse Volumes

Forthcoming Volumes

Annals PrePrints

Annals Extra

E-mail Alerts

Subscriptions & Orders

New Proposals

Author Guidelines

About Annals

Help

Get free Annals volume as a NYAS member: http://www.nyas.org/annalsreaderhw
Issue 993 coverNEUROPROTECTIVE AGENTS: Sixth International Conference Copyright © 2003 by the New York Academy of Sciences
description

This Volume
Table of Contents
Description
This Article
Full Text
Full Text (PDF)
Services
Similar articles in this journal
Similar articles in PubMed
Alert me to new issues of the journal
Download to citation manager
Citing Articles
Citing Articles via HighWire
Citing Articles via Google Scholar
Google Scholar
Articles by ZHUANG, H.
Articles by DORÉ, S.
Search for Related Content
PubMed
PubMed Citation
Articles by ZHUANG, H.
Articles by DORÉ, S.
Annals of the New York Academy of Sciences 993:276-286 (2003)
© 2003 New York Academy of Sciences

Potential Mechanism by Which Resveratrol, a Red Wine Constituent, Protects Neurons

HEAN ZHUANG, YUN-SOOK KIM, RAYMOND C. KOEHLER AND SYLVAIN DORÉ

Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University, Baltimore, Maryland, USA

Address for correspondence: Sylvain Doré, Ph.D., Johns Hopkins University, School of Medicine, Dept. of Anesthesiology and Critical Care Medicine, 600 N. Wolfe Street, (Blalock 1404A), Baltimore, MD 21287, USA. Voice: 410-614-4859; fax: 410-955-7165.
sdore{at}jhmi.edu
Ann. N.Y. Acad. Sci. 993: 276-286 (2003).

Polyphenolic compounds, such as resveratrol, are naturally present at high concentration in grape skin, seeds, and red wine. Resveratrol is present in cis and trans isoforms and the major trans isomer is the biologically active one. Epidemiologic studies have revealed a reduced incidence of cardiovascular risk associated with consumers of red wine; this has been popularized as the French paradox. Resveratrol has been shown to have significant antioxidant properties in a variety of in vitro and in vivo models. It can reduce ischemic damage in heart ischemia reperfusion injury and also in brain ischemia/reperfusion in rodent models. Due to the high rate of oxygen consumption in the brain, and especially low levels of antioxidant defense enzymes, this organ is particularly susceptible of free radical damage. Most of the protective biological actions associated with resveratrol have been associated with its intrinsic radical scavenger properties. We have investigated the possibility of other indirect pathways by which resveratrol can exert its neuroprotective abilities. We have specifically tested whether heme oxygenase neuroprotective enzyme could be stimulated after resveratrol treatment. Using primary neuronal cultures, resveratrol was able to significantly induce heme oxygenase 1, whereas vehicle control showed no effect. No detectable toxicity was quantified. It is well established that after stroke significant levels of intracellular heme levels increase. The source of free heme comes mainly from several heme-containing enzymes. Heme (iron-protoporphyrin IX) is a pro-oxidant and its rapid degradation by heme oxygenase is believed to be protective. Moreover, the generation of heme metabolites can also have their own intrinsic cellular properties. All together, increased heme oxygenase activity by resveratrol is a unique pathway by which this compound can exert its neuroprotective actions.

Key Words: Alzheimer's disease • antioxidant • cerebral ischemia • free radical • iron • oxidative stress • polyphenol • neurodegeneration • stroke

Abbreviations: AD Alzheimer's disease • BV biliverdin • BR bilirubin • CO carbon monoxide • CP450R cytochrome P450 reductase • ER endoplasmic reticulum • Fe iron • HO heme oxygenase • MTT 3-(4,5-dimethylthiazol-2yl)2,5-diphenyl tetrazolium bromide




This article has been cited by other articles:


Home page
Physiol. Rev.Home page
S. W. Ryter, J. Alam, and A. M. K. Choi
Heme Oxygenase-1/Carbon Monoxide: From Basic Science to Therapeutic Applications
Physiol Rev, April 1, 2006; 86(2): 583 - 650.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
F. H. Bach
Heme oxygenase-1: a therapeutic amplification funnel
FASEB J, August 1, 2005; 19(10): 1216 - 1219.
[Full Text] [PDF]


Home page
Cancer Res.Home page
K. Liby, T. Hock, M. M. Yore, N. Suh, A. E. Place, R. Risingsong, C. R. Williams, D. B. Royce, T. Honda, Y. Honda, et al.
The Synthetic Triterpenoids, CDDO and CDDO-Imidazolide, Are Potent Inducers of Heme Oxygenase-1 and Nrf2/ARE Signaling
Cancer Res., June 1, 2005; 65(11): 4789 - 4798.
[Abstract] [Full Text] [PDF]



footerLeft footerRight